Progressive DNA Hypomethylation as a Measure of Mitotic History and Potential Contributor to Replicative Senescence.

进行性 DNA 低甲基化作为有丝分裂历史的衡量标准和复制衰老的潜在贡献者。

基本信息

  • 批准号:
    10672187
  • 负责人:
  • 金额:
    $ 59.7万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2020
  • 资助国家:
    美国
  • 起止时间:
    2020-09-30 至 2025-04-30
  • 项目状态:
    未结题

项目摘要

PROJECT SUMMARY / ABSTRACT Cellular and molecular alterations that accumulate during cell division are considered to be contributors to aging phenotypes. Changes in epigenetic marks, including DNA methylation, have been widely documented in aging. This has spurred the development of epigenetic molecular clocks, which rely primarily on replication- independent gain of methylation at CpG islands. As molecular clocks tuned to chronological time across different tissue types with varying mitotic rates and histories, these clocks are not directly linked to mitotic cell division. In contrast, we have found that loss of DNA methylation at lamina-attached, late-replicating regions of the genome is closely tied to apparent mitotic history. We propose to use primary human cell culture to experimentally validate that mitosis is a driver of hypomethylation, and to explore the underlying mechanisms and consequences of this hypomethylation, to define genomic and chromatin features driving hypomethylation, and use this data to construct a mitotic molecular clock. In Specific Aim 1 we propose to use primary human cell culture to provide experimental evidence for the contribution of mitosis to PMD hypomethylation, and to disentangle the time-dependency and mitosis- dependency of the phenomenon using cell cycle inhibition. We will also investigate whether enhancing maintenance methylation machinery is able to counteract the progressive loss of DNA methylation. In Specific Aim 2 we propose to investigate whether DNA hypomethylation contributes to replicative senescence or associated phenotypes in primary human cell culture. We will investigate whether inhibition of maintenance methylation accelerates senescence, and whether progressive hypomethylation is extended in telomerase- immortalized primary human fibroblasts, contributing to premalignant phenotypes associated with such immortalization. We will also investigate whether accelerated senescence by progerin expression or supra- physiologic O2 leads to accelerated DNA hypomethylation. In Specific Aim 3 we will characterize the genomic and chromatin features that influence individual CpG hypomethylation rates. We will measure the rates of DNA hypomethylation of individual CpGs in six different primary human cell types and use this information to identify cell-type-specific, as well as universal genomic and chromatin drivers of hypomethylation. Finally, we will use elastic net regression on the assembled data to construct cell-type-specific and universal epigenetic mitotic clocks in Specific Aim 4. The preliminary studies strongly support the concept and feasibility of a DNA hypomethylation-based mitotic clock. The outcome of this proposed research could have important impacts on our understanding of the contribution of widespread hypomethylation to aging phenotypes, with potential implications for aging interventions. The availability of accurate molecular clocks specifically designed to measure mitotic history would provide a valuable molecular tool to characterize cells and tissues in human health and disease.
项目摘要/摘要

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

PETER W LAIRD其他文献

PETER W LAIRD的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('PETER W LAIRD', 18)}}的其他基金

Accelerated DNA Methylation Alterations in Hutchinson-Gilford Progeria Syndrome
Hutchinson-Gilford 早衰综合症中 DNA 甲基化的加速改变
  • 批准号:
    10780718
  • 财政年份:
    2023
  • 资助金额:
    $ 59.7万
  • 项目类别:
Integrative Cancer Epigenomic Data Analysis Center (ICE-DAC)
综合癌症表观基因组数据分析中心(ICE-DAC)
  • 批准号:
    10301849
  • 财政年份:
    2021
  • 资助金额:
    $ 59.7万
  • 项目类别:
Integrative Cancer Epigenomic Data Analysis Center (ICE-DAC)
综合癌症表观基因组数据分析中心(ICE-DAC)
  • 批准号:
    10474482
  • 财政年份:
    2021
  • 资助金额:
    $ 59.7万
  • 项目类别:
Integrative Cancer Epigenomic Data Analysis Center (ICE-DAC)
综合癌症表观基因组数据分析中心(ICE-DAC)
  • 批准号:
    10684894
  • 财政年份:
    2021
  • 资助金额:
    $ 59.7万
  • 项目类别:
Progressive DNA Hypomethylation as a Measure of Mitotic History and Potential Contributor to Replicative Senescence.
进行性 DNA 低甲基化作为有丝分裂历史的衡量标准和复制衰老的潜在贡献者。
  • 批准号:
    10450874
  • 财政年份:
    2020
  • 资助金额:
    $ 59.7万
  • 项目类别:
Progressive DNA Hypomethylation as a Measure of Mitotic History and Potential Contributor to Replicative Senescence.
进行性 DNA 低甲基化作为有丝分裂历史的衡量标准和复制衰老的潜在贡献者。
  • 批准号:
    10266860
  • 财政年份:
    2020
  • 资助金额:
    $ 59.7万
  • 项目类别:
Cellular Epigenetic Heterogeneity as a Predeterminant of Malignant Transformation Potential
细胞表观遗传异质性作为恶性转化潜力的决定因素
  • 批准号:
    10307617
  • 财政年份:
    2018
  • 资助金额:
    $ 59.7万
  • 项目类别:
Cellular Epigenetic Heterogeneity as a Predeterminant of Malignant Transformation Potential
细胞表观遗传异质性作为恶性转化潜力的决定因素
  • 批准号:
    10533777
  • 财政年份:
    2018
  • 资助金额:
    $ 59.7万
  • 项目类别:
Cellular Epigenetic Heterogeneity as a Predeterminant of Malignant Transformation Potential
细胞表观遗传异质性作为恶性转化潜力的决定因素
  • 批准号:
    10064579
  • 财政年份:
    2018
  • 资助金额:
    $ 59.7万
  • 项目类别:
Integrative Cancer Epigenomic Data Analysis Center (ICE-DAC)
综合癌症表观基因组数据分析中心(ICE-DAC)
  • 批准号:
    10005291
  • 财政年份:
    2016
  • 资助金额:
    $ 59.7万
  • 项目类别:

相似海外基金

The Aging Kidney Anatomy Study
衰老肾脏解剖学研究
  • 批准号:
    9243240
  • 财政年份:
    2011
  • 资助金额:
    $ 59.7万
  • 项目类别:
The macro- and micro- anatomy and pathology of the aging kidney
衰老肾脏的宏观和微观解剖学及病理学
  • 批准号:
    8022523
  • 财政年份:
    2011
  • 资助金额:
    $ 59.7万
  • 项目类别:
The macro- and micro- anatomy and pathology of the aging kidney
衰老肾脏的宏观和微观解剖学及病理学
  • 批准号:
    8425058
  • 财政年份:
    2011
  • 资助金额:
    $ 59.7万
  • 项目类别:
The macro- and micro- anatomy and pathology of the aging kidney
衰老肾脏的宏观和微观解剖学及病理学
  • 批准号:
    8602520
  • 财政年份:
    2011
  • 资助金额:
    $ 59.7万
  • 项目类别:
The macro- and micro- anatomy and pathology of the aging kidney
衰老肾脏的宏观和微观解剖学及病理学
  • 批准号:
    8223232
  • 财政年份:
    2011
  • 资助金额:
    $ 59.7万
  • 项目类别:
AUDITORY ANATOMY IN AGING RATS WITH EXTENDED LIFESPANS
寿命延长的老龄大鼠的听觉解剖学
  • 批准号:
    3117129
  • 财政年份:
    1988
  • 资助金额:
    $ 59.7万
  • 项目类别:
GROWTH AND AGING--ANATOMY OF SUBSTANTIA NIGRA
生长与衰老--黑质的解剖
  • 批准号:
    3476752
  • 财政年份:
    1987
  • 资助金额:
    $ 59.7万
  • 项目类别:
GROWTH AND AGING--ANATOMY OF SUBSTANTIA NIGRA
生长与衰老--黑质的解剖
  • 批准号:
    3476748
  • 财政年份:
    1987
  • 资助金额:
    $ 59.7万
  • 项目类别:
GROWTH AND AGING--ANATOMY OF SUBSTANTIA NIGRA
生长与衰老--黑质的解剖
  • 批准号:
    3476751
  • 财政年份:
    1987
  • 资助金额:
    $ 59.7万
  • 项目类别:
GROWTH AND AGING--ANATOMY OF SUBSTANTIA NIGRA
生长与衰老--黑质的解剖
  • 批准号:
    3476753
  • 财政年份:
    1987
  • 资助金额:
    $ 59.7万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了